-
Clinical Endpoints Study for BREAST NEOPLASMS
Regular price From €2.000,00 EURRegular priceUnit price per -
Expert mapping Study for BREAST NEOPLASMS
Regular price From €1.500,00 EURRegular priceUnit price per -
Safety Shield Study for ELACESTRANT
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for CAPIVASERTIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for MARGETUXIMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for TRASTUZUMAB DERUXTECAN
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for TUCATINIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for SACITUZUMAB GOVITECAN
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ALPELISIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for NERATINIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for PEMBROLIZUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ATEZOLIZUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for TALAZOPARIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for OLAPARIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ABEMACICLIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for RIBOCICLIB
Regular price From €800,00 EURRegular priceUnit price per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...
